From a raw material perspective, Sugar Cane is poised to maintain its dominance, holding an estimated 54.7% market share in ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...

Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...

Building on their success developing a cleaner way to make valuable organic acids, researchers from the Center for Advanced ...

Pharmaceuticals announced yesterday morning that the Food and Drug Administration approved the company’s abbreviated new drug ...

Understanding bees’ capabilities is, for Muth, a part of a fully-lived experience. “One of the joys of being human is being ...

Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.

Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...

Amphastar Pharmaceuticals (NASDAQ:AMPH) saw its stock increase by 4% after the company announced that the FDA had approved ...

Viatris (VTRS) stock gains as the FDA OK its generic Iron Sucrose Injection targeting Venofer marketed by Daiichi Sankyo (DSKYF) (DSNKY) and Vifor. Read more here.

Experts repeatedly emphasize that fruit does not cause inflammation. Barrie Kaiden notes that the recent study in Molecular ...

Compare cane sugar versus high-fructose corn syrup—and discover why cutting back on all added sugars is what really counts.